Literature DB >> 8102968

Influence of histamine receptor antagonists on the dynamics of the cutaneous hypersensitivity reaction in patients infected with schistosoma haematobium.

J R Snyman1, D K Sommers, M D Gregorowski.   

Abstract

The biphasic cutaneous hypersensitivity response elicited by intradermal administration of S. haematobium antigen to patients with schistosomiasis may be used as a model for drug effects on cell dynamics. As the effects of H1- and H2-blockade, and the possible involvement of H3-receptors, have not been elucidated, we have examined the effects of combinations of cetirizine, cimetidine and betahistine on the response of patients with confirmed schistosomiasis. The skin blister technique was used. After intradermal administration of antigen, blister fluid containing inflammatory cells was collected on microscope slides at 6 and 24 h, and a differential cell count was done; and the area of induration was measured at 0.25, 1, 6 and 24 h. These baseline tests were repeated after 3 days of pretreatment with cetirizine 20 mg/d, after the addition of cimetidine 1200 mg/d for 3 further days, and finally after adding on betahistine 32 mg/d for 3 days. Simultaneous H1- and H2-blockade with cetirizine plus cimetidine caused a significantly greater reduction in induration than cetirizine (H1-blockade) alone; the reductions from the baseline value were 70%, 78%, 89%, 97%, and 33%, 53%, 43%, 30%, at times 0.25, 1, 6 and 24 h, respectively. The triple combination with the addition of betahistine (H1- and H2-agonist and H3-antagonist) resulted in reductions of 37%, 63%, 95% and 97% at the same times. The most striking changes in cellular dynamics were a significant increase in eosinophil (6 h) and neutrophil (6 h) vacuolation, and enhancement of monocyte (24 h) and basophil (6 h) accumulation, when the betahistine was added.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102968     DOI: 10.1007/bf00315545

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

Review 1.  What are the differences between the H2-receptor antagonists?

Authors:  W Schunack
Journal:  Aliment Pharmacol Ther       Date:  1987       Impact factor: 8.171

2.  Effect of H2 blockade in the challenged allergic nose.

Authors:  C D Brooks; D Butler; C Metzler
Journal:  J Allergy Clin Immunol       Date:  1982-11       Impact factor: 10.793

3.  Effect of histamine H2-receptor antagonists on delayed hypersensitivity.

Authors:  J Avella; J E Madsen; H J Binder; P W Askenase
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

4.  Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study.

Authors:  J R Snyman; D K Sommers; M D Gregorowski; H Boraine
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  The presence of eosinophil-activating mediators in sera from individuals with Schistosoma mansoni infections.

Authors:  G Mazza; K J Thorne; B A Richardson; A E Butterworth
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

6.  Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs.

Authors:  S J Brown; S J Galli; G J Gleich; P W Askenase
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

7.  Cimetidine as modulator of the cell-mediated immune response in vivo using the tuberculin skin test as parameter.

Authors:  J R Snyman; E C Meyer; H S Schoeman
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

8.  Receptor effects of cetirizine.

Authors:  S H Snyder; A M Snowman
Journal:  Ann Allergy       Date:  1987-12

9.  Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.

Authors:  L Michel; C De Vos; J P Rihoux; C Burtin; J Benveniste; L Dubertret
Journal:  J Allergy Clin Immunol       Date:  1988-07       Impact factor: 10.793

10.  Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

Authors:  A E Butterworth; M Capron; J S Cordingley; P R Dalton; D W Dunne; H C Kariuki; G Kimani; D Koech; M Mugambi; J H Ouma
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.